Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hmpl-013
1. 1194506-26-7
2. Hmpl-013
3. Hmpl013
4. Fruquintinib [who-dd]
5. Fruquintinib(hmpl-013)
6. 6-(6,7-dimethoxyquinazolin-4-yl)oxy-n,2-dimethyl-1-benzofuran-3-carboxamide
7. Fruquintinib [usan]
8. 49dxg3m5zw
9. 6-(6,7-dimethoxyquinazolin-4-yloxy)-n,2-dimethylbenzofuran-3-carboxamide
10. 3-benzofurancarboxamide, 6-((6,7-dimethoxy-4-quinazolinyl)oxy)-n,2-dimethyl-
11. 6-[(6,7-dimethoxyquinazolin-4-yl)oxy]-n,2-dimethyl-1-benzofuran-3-carboxamide
12. 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-n,2-dimethylbenzofuran-3-carboxamide
13. Unii-49dxg3m5zw
14. Elunate
15. Fruquintinib [inn]
16. Fruquintinib; Hmpl-013
17. Fruquintinib (hmpl-013)
18. Schembl947183
19. Gtpl9428
20. Hmpl 013
21. Chembl4303214
22. Bcp15692
23. Ex-a2262
24. Nsc801000
25. Nsc829498
26. S5667
27. Who 10348
28. 6-[(6,7-dimethoxy-4-quinazolinyl)oxy]-n,2-dimethyl-3-benzofurancarboxamide
29. Akos026750586
30. Zinc114898570
31. Ccg-268573
32. Cs-5558
33. Db11679
34. Nsc-801000
35. Nsc-829498
36. Sb17123
37. Ncgc00481603-01
38. As-73141
39. Hmpl-013;hmpl013;hmpl 013
40. Hy-19912
41. B5864
42. A14393
43. C71641
44. A898991
45. Q27259271
46. B2693-470819
| Molecular Weight | 393.4 g/mol |
|---|---|
| Molecular Formula | C21H19N3O5 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 393.13247072 g/mol |
| Monoisotopic Mass | 393.13247072 g/mol |
| Topological Polar Surface Area | 95.7 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 579 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of colorectal carcinoma
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Fruquintinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fruquintinib, including repackagers and relabelers. The FDA regulates Fruquintinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fruquintinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fruquintinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fruquintinib supplier is an individual or a company that provides Fruquintinib active pharmaceutical ingredient (API) or Fruquintinib finished formulations upon request. The Fruquintinib suppliers may include Fruquintinib API manufacturers, exporters, distributors and traders.
click here to find a list of Fruquintinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Fruquintinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fruquintinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fruquintinib GMP manufacturer or Fruquintinib GMP API supplier for your needs.
A Fruquintinib CoA (Certificate of Analysis) is a formal document that attests to Fruquintinib's compliance with Fruquintinib specifications and serves as a tool for batch-level quality control.
Fruquintinib CoA mostly includes findings from lab analyses of a specific batch. For each Fruquintinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fruquintinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Fruquintinib EP), Fruquintinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fruquintinib USP).
LOOKING FOR A SUPPLIER?
